Announced Tue, 2 Jun · 19:37 IST

Submission of Intimation of Allotment of equity shares to promoters and promoter group.

Promoter Stake BuyOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+13.5%1-day move
₹52.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+13.5+26.0+30.4+48.1+47.3+61.0+48.2+49.9
Up moveDown movePending
AI summary

Novelix Pharmaceuticals has informed BSE that Srinidhi Fine Chemicals LLP, part of the promoter and promoter group, has acquired equity shares of the company. The shares were allotted upon conversion of warrants that had been earlier issued to the promoter group on a preferential allotment basis. The disclosure was filed under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. This is essentially the promoter group converting their existing warrants into actual equity shares, which increases their shareholding in the company.

Likely market impact

This is a positive signal of promoter confidence, as the promoter group is converting warrants into equity rather than letting them lapse. It increases the promoter's stake in the company and shows long-term commitment. For shareholders, this means greater promoter skin in the game, though it may also lead to some dilution depending on the size of the allotment.